Catastrophic Antiphospholipid Syndrome: A Complex Diagnosis in the Setting of Lupus.
antiphospholipid antibody syndrome (aps)
catastrophic antiphospholipid syndrome (caps)
intravenous immunoglobulins (ivig)
lupus mesenteric vasculitis
raynaud’s phenomenon
rituximab therapy
sle and lupus nephritis
systemic lupus erythema
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
accepted:
20
07
2023
medline:
5
9
2023
pubmed:
5
9
2023
entrez:
5
9
2023
Statut:
epublish
Résumé
This case report aims to highlight the importance of keeping catastrophic antiphospholipid syndrome (CAPS) high on the list of differentials in patients with lupus who present with digital ischemia and to understand the workup and treatment of the disease. Catastrophic antiphospholipid syndrome is a life-threatening variant of antiphospholipid syndrome (APS), and it is distinguished on the APS spectrum by its increased intensity and extent of thrombotic outcomes. Less than 1% of patients with APS develop CAPS and the demographic of patients affected are primarily females, 37 ± 14 years old, and have underlying primary APS or systemic lupus erythematosus (SLE). This is the case of a young female with lupus and end-stage renal disease secondary to lupus nephritis who presented to the emergency department for shortness of breath and bilateral leg swelling that eventually progressed to catastrophic antiphospholipid syndrome. She developed pulmonary embolisms, axillary hematoma, and bilateral lower extremity digital gangrene. The treatment course consisted of anticoagulation, steroids, intravenous immunoglobulin (IVIG), above-knee amputation, and eventually rituximab. Diagnosis and treatment of digital ischemia can be complex, especially, in the setting of lupus where the differential diagnosis is broad. A high index of suspicion for CAPS is essential for early diagnosis and treatment.
Identifiants
pubmed: 37667720
doi: 10.7759/cureus.42922
pmc: PMC10474971
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e42922Informations de copyright
Copyright © 2023, Liang et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Lupus. 2009 Sep;18(10):905-12
pubmed: 19671791
J Autoimmun. 2009 May-Jun;32(3-4):240-5
pubmed: 19324520
J Nephropathol. 2014 Jan;3(1):9-17
pubmed: 24644537
Autoimmun Rev. 2011 Sep;10(11):664-8
pubmed: 21569863
Autoimmun Rev. 2014 Sep;13(9):917-30
pubmed: 24824074
Semin Arthritis Rheum. 2018 Jun;47(6):877-882
pubmed: 29126718
Lupus. 2013 Nov;22(13):1327-35
pubmed: 24036580